Doctors say new gene-based treatments could offer long-term relief — and possible cures — for people living with sickle cell disease. Sickle cell disease has long shortened lives in the United States, ...
For generations, Sickle Cell Disease has been a devastating illness affecting millions of people around the world, ...
Scientists at St. Jude Children's Research Hospital and Northwestern University identified a previously unknown treatment opportunity for sickle cell disease and β-thalassemia. The discovery, ...
Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine This voice experience is generated by AI. Learn more. This ...
Stem cell transplantation is the most cost-effective option for long-term care of sickle cell disease in adults when compared with gene therapy and standard of care treatment, according to new ...
Millions of Americans have seen their health insurance premiums skyrocket since the Affordable Care Act subsidies expired at the end of December. Congress has worked to try and extend the COVID-19 era ...
The Scottish Medicines Consortium (SMC) has accepted exagamglogene autotemcel (Casgevy, Vertex Pharmaceuticals) for use within NHS Scotland to treat sickle cell disease (SCD) in patients aged 12 years ...
The first patient in Louisiana to receive genetically edited therapy for sickle cell disease went home this week after months in isolation at Manning Family Children's Hospital in New Orleans. Daniel ...
Sickle cell disease is the scourge of a person’s red blood cells. The inherited blood disorder, which disproportionately affects people in sub-Saharan Africa and India, can cause unbearable pain ...
In patients with sickle cell disease treated with ristoglogene autogetemcel, mean anti-sickling fetal hemoglobin levels were above 60% with a mean durable reduction in corresponding sickle hemoglobin ...
Sickle cell disease, a genetic blood disorder, disproportionately affects Black individuals, with one in 365 Black babies born with it in the U.S. New, high-cost gene therapies offer potential cures ...